PROFILE-V MEDTOXScan Drugs of Abuse Test System. For the rapid
Recall Z-1329-2013, part of FDA recall event 64800. See Medtox Diagnostics's company page.
Medtox Diagnostics Inc started this Class II device recall on Apr 5, 2013 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 12, 2013.
- Classification: Class II
- Started: Apr 5, 2013
- Status: Terminated
Review of validation information and customer complaints which indicated preliminary screen positive results for cocaine that were not positive on confirmatory testing.
- Product
- PROFILE-V MEDTOXScan Drugs of Abuse Test System. For the rapid, qualitative detection of drugs of abuse in human urine,
- Quantity
- 221,625
- Lots and codes
- Part No. 604018 - Lot No. 6821, 6822, 6823, 6824, 6825, 6831, 6832, 6841, 6851, 6852, 6853, 6861, 6862, 6863, 6864, 6865, 6866, 6867, 6868, 6871, 6881, 6891, 6892, 6901, 6902, 6903, 6904, 6911, 6912, 6921, 6922, 6931, 6942; Part No. 604019 - Lot No. 6321, 6331, 6341, 6351; Part No. 604020 - Lot No. 6361, 6371; Part No. 604022 - Lot No. 6551, 6552, 6561, 6562, 6563, 6564, 6571, 6581, 6582, 6583, 6584, 6591, 6592, 6593, 6601, 6602, 6603, 6611, 6612, 6621, 6622, 6623, 6631, 6632, 6641, 6651, 6652, 6661, 6671, 6672, 6681; Part No. 604026 - Lot No. 6041, 6051; Part No. 604028 - Lot No. 6051, 6061,…
- Distribution
- Worldwide distribution: USA (nationwide) and in the country of: Canada.
- Recalling firm
- Medtox Diagnostics Inc, Burlington, NC, United States
- How the firm notified
- Letter
- FDA classified
- May 16, 2013
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports